nature neurOSCIenCe a r t I C l e S DNA methylation is an epigenetic mechanism by which methyl groups are covalently coupled to the C-5 position of cytosine (5mC) predominantly at CpG dinucleotides 1 . It is generally accepted that DNA methylation is relatively stable and mediates long-term gene silencing. This presents an appealing mechanism for long-lasting transcriptional regulation underlying neural plasticity associated with learning and memory and neuropsychiatric disorders. However, accumulating evidence indicates that DNA methylation in brain is reversible 2-5 , which suggests the existence of DNA demethylation machinery. Although several candidates have been proposed as DNA demethylases 6 in mammals, a major breakthrough came in 2009, when TET1 was recognized to convert 5mC to 5hmC (refs. 7,8). Soon after, two other TET family members, TET2 and TET3, were also shown to have 5mC hydroxylase activity 9,10 . It was further revealed that all three TETs successively oxidize 5mC to 5hmC, 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) 11, 12 . Thus, 5mC oxidation is a plausible DNA demethylation mechanism. In fact, studies have discovered several pathways leading to 5hmC-mediated DNA demethylation [13] [14] [15] . For example, TET-catalyzed 5hmC conversion into 5fC and 5caC can be efficiently removed from DNA by thymine-DNA glycosylase. Subsequent repair of the resulting abasic site via base excision repair can generate an unmethylated cytosine. Alternatively, 5hmC deamination can remove 5hmC and replace it with unmethylated cytosine 16 .
a r t I C l e S DNA methylation is an epigenetic mechanism by which methyl groups are covalently coupled to the C-5 position of cytosine (5mC) predominantly at CpG dinucleotides 1 . It is generally accepted that DNA methylation is relatively stable and mediates long-term gene silencing. This presents an appealing mechanism for long-lasting transcriptional regulation underlying neural plasticity associated with learning and memory and neuropsychiatric disorders. However, accumulating evidence indicates that DNA methylation in brain is reversible [2] [3] [4] [5] , which suggests the existence of DNA demethylation machinery. Although several candidates have been proposed as DNA demethylases 6 in mammals, a major breakthrough came in 2009, when TET1 was recognized to convert 5mC to 5hmC (refs. 7,8) . Soon after, two other TET family members, TET2 and TET3, were also shown to have 5mC hydroxylase activity 9, 10 . It was further revealed that all three TETs successively oxidize 5mC to 5hmC, 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) 11, 12 . Thus, 5mC oxidation is a plausible DNA demethylation mechanism. In fact, studies have discovered several pathways leading to 5hmC-mediated DNA demethylation [13] [14] [15] . For example, TET-catalyzed 5hmC conversion into 5fC and 5caC can be efficiently removed from DNA by thymine-DNA glycosylase. Subsequent repair of the resulting abasic site via base excision repair can generate an unmethylated cytosine. Alternatively, 5hmC deamination can remove 5hmC and replace it with unmethylated cytosine 16 .
We have just started to understand the distribution and function of these forms of DNA epigenetic modifications and TET oxidases in the genome, which are essential in a range of biological processes such as embryonic development, stem cell function and cancer formation [13] [14] [15] . Of note, 5hmC is most abundant in brain compared with other organs 7, 17, 18 , suggesting that is important in neural function 19 . Indeed, emerging evidence indicates that TET1 regulates active hippocampal DNA demethylation 16, 20, 21 , cognition 22 , and learning and memory 20, 21, 23 . However, the influence of TET proteins and 5hmC on the regulation of gene transcription in brain and their role in brain disorders remain largely unknown.
We set out to determine whether TET proteins and 5hmC are involved in the epigenetic regulation of cocaine action. Repeated cocaine exposure induced persistent changes in gene expression in the nucleus accumbens (NAc) 24 , a key brain structure of the reward circuitry. Epigenetic mechanisms are important for this process as well as in downstream neural and behavioral plasticity 25, 26 . We found decreased expression of TET1, but not TET2 or TET3, in NAc after repeated cocaine administration. Using viral manipulations, we established that decreased TET1 served to enhance behavioral responses to the drug. In concert with TET1 downregulation, repeated cocaine increased the enrichment of 5hmC at a large subset of genes that are involved in drug addiction. Such changes were concentrated at both putative enhancers a r t I C l e S TET1 normally functions to negatively regulate cocaine reward and that cocaine-induced suppression of TET1 in NAc contributes to enhanced drug sensitivity.
5hmC profiling in NAc after repeated cocaine administration Given that TET1 oxidizes 5mC into 5hmC, we next investigated cocaine regulation of these DNA modifications in NAc. First, we quantified total levels of 5mC and 5hmC 5, 27 and found no global change in either (Fig. 2a) . This suggests that any alterations in 5hmC may be locus specific. Alternatively, given the ~2-fold greater abundance of Tet2 and Tet3 mRNAs in NAc (Supplementary Fig. 3 ), it is conceivable that they compensate for TET1 downregulation despite their lack of regulation by cocaine (Fig. 1a,c) . To test these possibilities, we mapped 5hmC genome-wide using a 5hmC chemical labeling capture protocol 19 that provided high-quality sequencing results (Supplementary Table 1 ).
In total, we identified 208,801 5hmC peak regions from NAc of saline-treated control mice and 226,185 peaks from cocaine-treated mice. Although the gross chromosomal distribution of 5hmC peak regions was equivalent between saline-and cocaine-treated conditions, we found that sex chromosomes had extremely low 5hmC enrichment ( Supplementary Fig. 4a ). We also identified 11,511 regions that displayed differential levels of 5hmC after repeated cocaine (Supplementary Table 2 ), which appeared to be evenly distributed across all autosomes (Supplementary Fig. 4b ). These 5hmC differential regions were heavily enriched in gene bodies (~55%) and intergenic regions (~34%), as determined by calculating the percentage of differential region counts across all genomic features ( Fig. 2b and Supplementary Fig. 4c ). In addition, we measured the density of these 5hmC alterations across various genomic regions and found intergenic regions, gene promoters and gene bodies among the top categories (Fig. 2c) . Thus, we speculated that 5hmC might have functional roles in both intergenic and genic regions in cocaine action. and gene bodies, and correlated with increased expression of these genes as well as with their alternative splicing. Notably, we found that cocaine-induced increases in 5hmC at representative loci in NAc were mimicked following Tet1 knockdown alone. In sum, our findings not only advance our understanding of the epigenetic mechanisms involved in cocaine action, but also provide fundamentally new insight into how 5hmC regulates gene expression in the brain.
RESULTS

Repeated cocaine decreases TET1 in NAc to enhance behavioral responses
We first examined Tet mRNA regulation in mouse NAc 24 h after repeated cocaine exposure. Quantitative PCR (qPCR) revealed that, of the three known Tet family members, only Tet1 was downregulated (Fig. 1a) . Quantitative western blotting and immunohistochemistry revealed a concomitant decrease in TET1 protein, but not TET2 or TET3, in NAc after repeated cocaine (Fig. 1b,c and Supplementary  Fig. 1a,b) . Notably, we found a ~40% decrease in TET1 mRNA in the NAc of cocaine-addicted humans examined postmortem (Fig. 1d ). These data demonstrate that TET1 expression is subject to dynamic regulation in the adult brain and implicate TET1 in cocaine action.
To investigate directly whether altered levels of TET1 in NAc regulate behavioral responses to cocaine, we used stereotaxic viral manipulations to express Tet1 shRNA and knockdown TET1 selectively in the adult NAc (Supplementary Figs. 1c and 2a,b) . We then analyzed the mice in an unbiased cocaine conditioned place preference procedure, which provides an indirect measure of drug reward. Tet1 knockdown with either of two independent shRNA constructs robustly enhanced cocaine place conditioning (Fig. 1e,f) . Conversely, we used a previously validated AAV-TET1 vector to express TET1 (ref. 16) in NAc (Supplementary Fig. 2c ) and found decreased cocaine preference (Fig. 1g) , which indicates that TET1 expression in the NAc is sufficient to suppress cocaine reward. Together, these data suggest that in NAc by immunohistochemistry 24 h after repeated cocaine (unpaired t test, P = 0.035, t(22) = 2.245, n = 12 per group). (c) Western blot analysis revealed a selective decrease in TET1 protein 24 h after repeated cocaine (unpaired t test, TET1: Welch correction, P = 0.019, t(25) = 2.500, n = 18 per group; TET2: P = 0.970, t(28) = 0.038, n = 16 per group; TET3: P = 0.972, t(35) = 0.035, saline n = 19, cocaine n = 18). A representative blot is shown with β-actin as a loading control. (d) qPCR analysis showed a selective decrease in TET1 mRNA, but not TET2 or TET3, in NAc of humans addicted to cocaine (unpaired t test, TET1: P = 0.006, t(38) = 2.913, control n = 21, addicted n = 19; TET2: P = 0.065, t(36) = 1.903, n = 19 per group; TET3: P = 0.463, t(34) = 0.743, n = 18 per group.). (e) Conditioned place preference (CPP) for cocaine with viral Tet1 shRNA knockdown (KD) construct#1 in NAc (unpaired t test Welch correction, P = 0.038, t(21) = 2.221, n = 15 for control and 12 for KD). (f) CPP for cocaine with viral Tet1 shRNA KD construct#2 in NAc (unpaired t test, P = 0.031, t(22) = 2.303, n = 12 per group). (g) CPP for cocaine with AAV-TET1 overexpression (OE) in NAc (unpaired t test, P = 0.027, t(23) = 2.358, n = 14 for control and 11 for OE group). Data are presented as mean ± s.e.m. in a, c and d. Box plots present, in ascending order, minimum sample value, first quartile, median, third quartile, maximum sample value. *P < 0.05, **P < 0.01. Sal, saline; Coc, cocaine. β-actin npg a r t I C l e S 5hmC dynamics at putative enhancers We first characterized 5hmC dynamics at putative enhancer regions. Enhancers are DNA regulatory elements that are critical in gene expression, with many residing long distances away from gene promoters. It is estimated that hundreds of thousands of enhancers exist in the genome, vastly outnumbering the ~20,000 coding genes. Enhancers are also associated with characteristic histone modification patterns 28 . For example, H3K27ac and H3K4me1 co-binding has been widely recognized as a signature of active enhancers that engage in transcription regulation [28] [29] [30] [31] [32] . In accordance with these studies, to define putative enhancers in NAc, we performed chromatin immunoprecipitation sequencing (ChIP-seq) for H3K4me1 and H3K27ac (Supplementary Table 1) . We also included a previously reported ChIP-seq data set for H3K4me3 (ref. 33) , which is highly enriched at promoters, to exclude promoters from our predicted enhancers.
When we plotted our ChIP-seq data of H3K4me1 and H3K27ac over putative mouse brain enhancers derived from the ENCODE database (http://genome.ucsc.edu/ENCODE/), both display enriched binding at enhancer regions (Supplementary Fig. 5 ). This analysis suggests good antibody specificity and sequencing quality. Similarly, 5hmC showed enrichment at these putative enhancer regions genome-wide. We then performed a study on chromatin states 28, 32 , or the combination of epigenetic modifications, using ChromHMM 32 . We applied combinatorial patterns of H3K4me1 and H3K27ac, together with 5hmC, to define several distinct chromatin states (Online Methods and Fig. 2d) 32 . We first excluded state 8 from our putative enhancer analysis because of its high levels of H3K4me3, which reflect promoter presence (Fig. 2d) . We then focused on the chromatin states that were characterized by enhancer marks H3K4me1 and H3K27ac, as well as 5hmC (states 4, 5 and 6; Fig. 2d) . To further validate our definition of putative enhancers by H3K4me1 and H3K27ac ChIP-seq through ChromHMM, we applied a second algorithm (RFECS, random forest based enhancer identification from chromatin states) that reportedly accurately predicts enhancers based solely on H3K4me1 and H3K27ac ChIP-seq 28 . We found that the enhancer predictions from the two algorithms had >70% overlap, which provides validity for our enhancer predication approach. We next performed ChIP-qPCR to validate H3K4me1 and H3K27ac enrichment at multiple predicted putative enhancer sites (Supplementary Fig. 6 ). Notably, these putative enhancer sites exhibited various degrees of enrichment of P300 (Supplementary Fig. 6 ), a transcription co-activator that also marks enhancer regions. Thus, these findings further support our method of identifying putative enhancers.
Our analyses revealed robust regulation of chromatin states at putative enhancer regions in NAc by cocaine. A subgroup of putative enhancers displayed increased prevalence of H3K27ac together with either increased 5hmC (switch from state 6 to 4) or decreased 5hmC (switch from state 6 to state 5) after repeated cocaine (Fig. 2d,e) . 54 npg a r t I C l e S Given that enhancers can regulate expression of neighboring proteincoding genes, we assigned them to the nearest genes as plausible targets (see Discussion for limitations of this approach). We recognized 739 and 846 cocaine-specific chromatin state 4 and state 5 putative enhancer genes, respectively (Supplementary Table 3) . Notably, the vast majority (>90%) of these genes' enhancers were under state 6 at saline condition (Fig. 2f) , which indicates robust 5hmC dynamics-a gain in 5hmC in switching from state 6 to state 4 or a loss of 5hmC in switching from state 6 to state 5-after cocaine administration. Gene ontology (GO) analysis of cocaine-specific state 4 and state 5 putative enhancer genes revealed enrichment in several meaningful categories ( Fig. 2g and Supplementary Table 4 ). For example, cocaine-specific state 4 putative enhancer genes included C2H2 zinc finger proteins that bind to methylated DNA 34 and immune genes that are implicated in neuronal plasticity 35 . In contrast, cocainespecific state 5 putative enhancer genes were mainly clustered in neurotransmitters as well as many chromatin assembly genes, both of which are important for neural plasticity and memory 36 . As transcription factors are increasingly recognized to bind to enhancers to achieve their regulatory roles, we performed a motif analysis of the cocaine-specific state 4 and state 5 putative enhancer regions and found substantial enrichment of a handful of candidate transcription factors (Supplementary Table 5 ). Some of these same transcription factors were deduced from our recent analysis of cocaine regulation of histone modifications and alternative splicing 33 , which suggests that follow-up studies are necessary.
5hmC regulation of alternative splicing and transcription Next, we explored the influence of altered 5hmC enrichment at coding regions of NAc in response to repeated cocaine. We identified enrichment of 5hmC changes at flanking exon boundaries (Fig. 3a) , which implicates 5hmC in mRNA alternative splicing. Furthermore, we overlaid our 5hmC profiling with RNA-seq 24 h after repeated cocaine or saline treatment, the same time point used for our 5hmC experiments. We found enrichment of 5hmC-increased regions (35 regions) at splicing sites of upregulated splicing isoforms (1,488 sites), as well as enrichment of 5hmC-decreased regions (18 regions) at splicing sites of downregulated isoforms (1,536 sites; Fig. 3b,c) . To the best of our knowledge, this is the first documentation of detailed alternative splicing sites coupled with 5hmC changes in brain (Supplementary Table 6 ). Together, our findings support the involvement of 5hmC at exonic regions in alternative RNA splicing in response to cocaine.
To complement our transcriptome analysis at 24 h of withdrawal from repeated cocaine treatment, we generated another RNA-seq data set, which was obtained 4 h after a subsequent challenge dose of cocaine (Fig. 4a) . This data set better reflects altered inducibility of genes in contrast with the 24-h data set, which reflects longer lasting or steady-state changes in gene expression. Notably, cocaine-induced increases in 5hmC at gene bodies correlated significantly with increased gene expression after 24 h of withdrawal from cocaine exposure (odds ratio (observation/expectation) = 2.5, P = 4 × 10 −3 , 24 of 356 upregulated genes displayed increased 5hmC in gene body regions; Fig. 4b ), and this overlap was even more significant with genes that were induced by a cocaine challenge (odds ratio = 3.5, P = 10 −6 ; odd ratio = ~1, P > 0.05 for all other cross comparisons; Fig. 4b ). We observed a pre-existing increase in 5hmC enrichment in 31 of 261 genes upregulated at 4 h ( Table 1) . GO analysis indicated that these overlapping genes were concentrated in certain meaningful categories that have pivotal roles in drug addiction, such as longterm plasticity, synaptic transmission and glutamate neurotransmitter ( Table 1 and Supplementary Fig. 7) . These indicate that repeated cocaine increased 5hmC correlates with both steady-state gene induction and gene inducibility in response to a subsequent cocaine challenge. Of note, however, the enhancer changes did not correlate genome-wide with gene expression (see Discussion).
To validate our findings, we carried out qPCR to measure gene expression and oxidative bisulfite sequencing (oxBS-seq) to quantify 5hmC alterations 37 . We first confirmed induction of several genes at the 24-h time point (Adcy1, Itpr1, Hrk and Nsph4; Fig. 4c ) or 4 h npg a r t I C l e S after a cocaine challenge (Adcy1, Akap6 and Ntrk2; Fig. 4d ) that were consistent with our RNA-seq findings. We then chose two genomic regions from our 5hmC-seq analysis for validation with oxBS-seq (Supplementary Fig. 8 ). This experiment confirmed induction of 5hmC at each of these genes in an independent cohort of animals (Fig. 4e) .
To establish a causal role for the cocaine-induced TET1 downregulation in mediating the increased enrichment of 5hmC at gene targets, we investigated whether TET1 knockdown in NAc by itself in cocaine naive mice is able to mimic the 5hmC changes seen after cocaine. Indeed, for the six loci that we studied, five displayed robust induction of 5hmC following TET1 knockdown (Fig. 5) .
Repeated cocaine-induced 5hmC regulation can be long lasting 5hmC is generally considered to be a transient intermediate state between 5mC and 5fC or 5caC that ultimately leads to unmethylated cytosine. However, 5hmC exists at much more abundant levels-particularly in brain-than 5fC or 5caC. Thus, we speculated that 5hmC might also serve as a stable epigenetic mark and tested whether some of the cocaine-induced changes in 5hmC persist long after cocaine exposure.
Of the genes we studied (Fig. 4) , we demonstrated sustained induction of three of them (Adcy1, Hrk and Ntrk2; Fig. 6 ) 1 month after repeated cocaine treatment, and this induction was associated with increases in 5hmC (Fig. 6) , effects not seen for the other genes (data not shown). These findings indicate that 5hmC can be a persisting epigenetic mark associated with prolonged transcriptional activation. Given that Adcy1 and Ntrk2 are important in drug addiction [38] [39] [40] , the sustained induction of 5hmC might contribute to persistent cocaine actions in brain.
DISCUSSION
Our results reveal previously unappreciated roles for TET enzymes and 5hmC in the molecular and behavioral effects of cocaine. We observed selective downregulation of TET1 in NAc in response to chronic cocaine administration, which serves to promote behavioral responses to the drug. We found a link between such TET1 downregulation to alterations of 5hmC at putative enhancer regions and gene bodies, changes associated with altered gene expression and alternative splicing. Together, these findings reveal previously unknown epigenetic mechanisms that are involved in cocaine action.
Despite the fact that most studies of 5mC have focused on gene promoters, our finding that 5hmC alterations in gene bodies were associated with altered gene transcription is consistent with previous observations of 5hmC enrichment at gene bodies in stem cells 41 Genomic coordinate of the locus is shown. A summary of 5hmC frequency at each CpG site is demonstrated in a line chart and the mean 5hmC levels of individual alleles is displayed in a bar graph (n = 2-4 biological replicates per condition). Box plots present, in ascending order, minimum sample value, first quartile, median, third quartile, maximum sample value. *P < 0.05, **P < 0.01. Sal, saline; Coc, cocaine. npg a r t I C l e S npg a r t I C l e S and during neural development 19 . Although the exonic enrichment of 5hmC is suggestive of a role in pre-mRNA alternative splicing 42 , our study is, to the best of our knowledge, the first to directly associate regulation at alternative splicing sites with altered splicing. We recently found that cocaine induces an order of magnitude more changes in alternative splicing than changes in total transcript levels 33 . Our results therefore implicate 5hmC in this prominent form of transcriptional regulation. We also identified numerous cocaine-induced changes in 5hmC at putative enhancer sites. Using H3K4me1 and H3K27ac as tentative marks of active enhancers [28] [29] [30] [31] [32] , we studied 5hmC dynamics at enhancer regions in response to cocaine. We found that 5hmC was enriched at enhancer regions in NAc and that such enrichment was regulated by cocaine. By assigning cocaine-regulated putative enhancers to the nearest genes to probe for potential enhancer targets, we found that the gene targets were enriched in interesting GO categories. However, we failed to detect a correlation between these regulated enhancers and our RNA-seq transcriptome profiling, emphasizing that the degree to which modifications at enhancer sites control dynamic regulation of gene expression in brain remains uncertain. Moreover, although defining enhancer-regulated targets by proximity alone has been a fruitful approach 29 , we must emphasize its limitations. Many enhancers bypass hundreds of kilobases of interspersed sequence on the linear genome to interact with distant targets via chromosomal looping. Accordingly, studying the three-dimensional structure of chromatin can provide a precise prediction of enhancer target genes 43 . However, studies of higher order genome architecture are just beginning to be applied to the brain and major advances are needed before they can be applied to a microdissected brain region such as the NAc. Another means by which enhancers influence transcription is by directing the expression of a group of non-coding RNAs known as enhancer RNAs (eRNAs) 44 that are particularly sensitive to neural activity. However, many eRNAs are nonpolyadenylated 45 , which is beyond the detection range of our poly-A selection-based Illumina RNA-seq protocol (Online Method). Moreover, given the cell type-specific feature of enhancers 30 , enhancer-driven transcriptional regulation likely occurs in only a subtype of cells, which would be difficult to examine using our current heterogeneous tissue dissections and impossible to isolate in sufficient quantities for more selective analysis. Although functional implications of putative enhancers are often confirmed in in vitro reporter assays, this approach still requires further validation in vivo. Thus, continued technology development 43, 46, 47 will allow future investigations of enhancer regulation in NAc in addiction models. Nevertheless, despite these limitations, our Figure 5 Tet1 knockdown in NAc of cocaine naive mice induces 5hmC at cocaine-regulated loci. oxBS-seq revealed increased 5hmC at Adcy1 (paired t test, P = 0.0002, t(6) = 8.017), Akap6 (paired t test, P = 0.019, t(13) = 2.684), Hrk (paired t test, P = 0.022, t(3) = 4.356), Itpr1 (paired t test, P = 0.011, t(5) = 3.945) and Ntrk2 (paired t test, P = 0.027, t(3) = 4.082) from NAc of naive animals that received viral Tet1 shRNA knockdown as in Figure 1e . A summary of 5hmC frequency at each CpG site is demonstrated in a line chart and the mean 5hmC level of individual alleles is displayed in a bar graph (n = 2-4 biological replicates per condition). Box plots present, in ascending order, minimum sample value, first quartile, median, third quartile, maximum sample value. *P < 0.05, ***P < 0.001. Control, control shRNA; KD, knockdown with Tet1 shRNA. Figure 5 . N = 2-3 biological replicates per condition. Box plots present, in ascending order, minimum sample value, first quartile, median, third quartile, maximum sample value. *P < 0.05, **P < 0.01. Sal, saline; Coc, cocaine. npg a r t I C l e S putative identification of enhancer regions suggests the involvement of 5hmC in enhancer state dynamics. Our analysis also identified several transcription factor motifs at cocaine-regulated putative enhancer regions, which is consistent with the emerging role of transcription factors in non-coding enhancer regions 29 .
Our finding that cocaine-induced 5hmC enrichment in NAc positively correlates with increased gene expression is consistent with previous reports 48 . 5hmC may promote such transcription activation through dissociation of 5mC binding protein repressors or recruitment of previously unknown effector proteins 15 . Previous research proposed that a decrease in TET1 leads to less 5mC conversion to 5hmC, and thus to promoter hypermethylation and transcription repression [20] [21] [22] . Our demonstration that TET1 downregulation leads to a substantial overlap between increased 5hmC and gene induction after cocaine appears to counter this view. There are several possible explanations. First, the previous studies focused on gene promoters, whereas the alterations in 5hmC that we identified occurred at gene bodies, and it is known that DNA modifications exert different effects at these distinct regions 49 . Second, none of the earlier studies compared 5hmC landscapes with genome-wide transcriptome profiling, as we did, and instead used candidate gene approaches. Third, although 5mC oxidation patterns were not examined in some studies 20, 21 , TET1 knockout mice did display elevated 5hmC at selected genes 22 , suggesting that TET1 deficiency can cause increased 5hmC, at least at certain loci. Fourth, if TET1 downregulation causes universal DNA hypermethylation, it is hard to explain why there is a global decrease in 5mC when TET1 is repressed in mouse hippocampus in the context of seizures 21 . In fact, TET1 has been implicated in both transactivation and repression 41, 50 . In TET1-depleted embryonic stem cells, more TET1 targets were upregulated than downregulated. It is hypothesized that this TET1 effect might reflect its normal coupling with repressor complexes 41, 50 . Moreover, how 5hmC conversion into 5fC or 5caC is affected by TET1 deficiency is unknown. An interruption of this process after TET1 loss might contribute to 5hmC accumulation. Notably, we found that TET1 knockdown in NAc caused similar induction of 5hmC (Fig. 5) , as observed after cocaine exposure, which supports a causal role of TET1 downregulation in 5hmC induction at the genomic loci that we investigated. However, the lack of a global DNA methylation change (Fig. 2a) , the observation that TET1 knockdown did not mimic all cocainetriggered 5hmC increases in NAc and possible non-enzymatic activities of TET1 (ref. 21) suggest several directions for future research. In addition, it would be interesting to explore a possible role for TET2 and TET3 in cocaine action, even though they are not regulated in NAc by cocaine, given their relative abundance in this brain region ( Supplementary  Fig. 3) . Nevertheless, our data indicate that TET1 has at least some unique targets in NAc that are not compensated by TET2 or TET3 and that demonstrate 5hmC induction in response to cocaine.
It has been challenging to correlate DNA epigenetic modifications and gene expression regulation genome-wide in brain under several experimental procedures. This is possibly because available methodologies are not sufficiently sensitive to capture minor changes of both simultaneously, most studies have focused on a subset of genomic regions (for example, promoters) and might have missed important regulation elsewhere, sodium bisulfite sequencing technology used to date for DNA methylation analysis do not differentiate 5hmC and 5mC, which can exert opposite effects on transcription, and a change in DNA methylation can reflect not only an alteration in steady-state gene expression, but also a gene's poising for future transcription. Our study addresses several of these questions, as we found, genomewide in a discrete region of adult brain, that dynamic regulation of 5hmC correlated with several features of gene expression, including alternative splicing of primary transcripts, alterations in steady-state levels of expression and future inducibility, and that some of the 5hmC changes were long lasting.
In summary, our results establish 5hmC as a previously unknown epigenetic mark in cocaine action. By mapping 5hmC in NAc in response to repeated cocaine exposure, we identified numerous target genes that now warrant investigation for their role in cocaine action. That some of the genes identified have previously established roles in cocaine addiction [46] [47] [48] supports the importance of examining the targets. A prominent feature of drug addiction is that, once it is formed, those addicted can have life-long behavioral abnormalities, which implicates stable brain changes in this process 24 . Our findings present 5hmC as one plausible underpinning mechanism. The next important steps are to carry out more sophisticated behavioral experiments of drug addiction, such as self-administration, to probe a role of 5hmC at particular genomic loci in NAc in the development and maintenance of addiction. Such work has the potential of generating new means of interrupting this process for therapeutic goals.
METHODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METHODS
Animals and cocaine administration. Adult male C57BL/6J mice (Jackson Lab) 8-10 weeks old were used in this study. They were housed four to five per cage on a 12-h light-dark cycle at constant temperature (23 °C) with free access to food and water ad libitum. All animals were experimentally naive. They were habituated for at least 1 week before experimentation and assigned randomly to experimental groups. All mice were from at least three litters in each group. All behavioral experiments were performed during the light cycle. All animal protocols were approved by the Institutional Animal Care and Use Committee of Mount Sinai. All experiments were carried out by experimenters blind to animal treatment conditions whenever possible (this includes all behavioral assays, RNA/DNA isolation, IHC and western blotting).
Animals received daily intraperitoneal injections for 7 consecutive days of cocaine (Sigma) at 20 mg per kg body weight (repeated cocaine). Mice were used 24 h after the final injection. For the 4-h experiments, mice were killed 4 h after a challenge dose of cocaine (20 mg per kg, intraperitoneal) administered 24 h after repeated cocaine. Control mice for all groups received saline injections. Bilateral 14-gauge NAc punches were taken from each animal. Unless otherwise noted, NAc punches from five mice were pooled for one replicate in ChIP assay, whereas NAc punches from one mouse were used as one replicate for all other RNA/DNA/protein assays.
Human samples. NAc samples from humans addicted to cocaine were acquired from the brain bank at McGill University. Brain tissues were from addicted subjects and healthy control male adult subjects of French Canadian ancestry. The cohort was composed of 37 male subjects, ranging in age between 15 and 66 years. All subjects died suddenly without a prolonged agonal state or protracted medical illness. In each case, the cause of death was ascertained by the Quebec Coroner Office, and a toxicological screen was conducted with tissue samples to obtain information on medication and illicit substance use at the time of death. The subject group consisted of individuals who met the Structured Clinical Interview for DSM-IV (Diagnostic and Statistical Manual of Mental Disorders-IV) Axis I Disorders: Clinician Version (SCID-I) criteria for cocaine dependence. The control group comprised subjects with no history of cocaine dependence and no major psychiatric diagnoses. All subjects died suddenly from causes that had no direct influence on brain tissue. Groups were matched for mean subject age, refrigeration delay, and pH. For all subjects, psychological autopsies were performed as described previously (see ref. 51 for further details on patient and control demographics).
RnA isolation and qPcR. Brain samples were homogenized in Trizol (Invitrogen) and processed according to the manufacturer's instructions. RNA was purified with RNeasy Micro columns (Qiagen) and spectroscopy confirmed that the RNA 260/280 rations were >1.8. RNA was then reverse transcribed using a Bio-Rad iScript Kit (Biorad). cDNA was quantified by qPCR using SYBR Green (Quanta). Each reaction was run in duplicate or triplicate and analyzed following the ∆∆Ct method as previously described 5 using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and B2M as normalization control. All experiments were repeated at least twice. All primer sequences are listed in Supplementary Table 7. Immunohistochemistry. Coronal sections 25 µm thick were prepared on a microtome and were processed with a regular free floating immunohistochemistry protocol. After 3 washes in phosphate-buffered saline and a blocking with 4% (wt/vol) BSA, 0.4% (vol/vol) Triton X-100 in phosphate-buffered saline, brain sections were incubated with antibodies to TET1 (Millipore cat# 09-872, 1:500), H1 (Abcam cat# ab62884, 1:2,000), DARP32 (Cell signaling cat# 2306, 1:1,000), or GFP (Molecular Probes cat# A11120, 1:1,000) at 4 °C overnight. They were then incubated with secondary antibodies: Alexa 488-or Alexa 647-conjugated secondary antibody (Molecular Probes) at room temperature (23-25 °C) for 2 h. Quantification of TET1 immunoreactivity was also determined with a Licor system by using Odyssey software as previously described 52 . Results are presented as integrated intensity values per mm 2 and are presented as means ± s.e.m. Values for histone linker protein H1 were used as normalization controls. Ratios of TET1 over total H1 were analyzed, and Student's t test was used to compare means for each brain region. Differences were considered significant at value of P < 0.05. These IHC experiments were successfully repeated at least once.
western blot analysis. The nucleus accumbens was dissected from mice and subjected to a subcellular fraction protocol that produces multiple cell fractions, including a nuclear fraction, using established methods 53 . Specifically, mouse nucleus accumbens was solubilized in HEPES-buffered sucrose (0.32 M sucrose, 4 mM HEPES, with protease and phosphatase inhibitors, pH = 7.4) using a teflon homogenizer at 400 rpm and approximately 40 up and down strokes. The solution then was centrifuged at 1,000 g at 4 °C for 10 min. The resulting pellet (p1 fraction) was isolated and resuspended in HEPES-buffered sucrose and again centrifuged at 1,000 g at 4 °C; this step was repeated three times. Next, the p1 pellet was resuspended in radio-immunoprecipitation buffer (RIPA, pH = 7.4). The resulting purified p1 fraction is enriched for cell nuclei. Protein concentration was determined using a DC protein assay (Bio-Rad). Equal amounts of protein were then mixed with 5× sample loading buffer and boiled at 95°C for 5 min. Samples were separated using SDS-PAGE, and protein levels quantified using densitometry (Image J). All western blot analyses were successfully repeated at least once. Antibodies to TET1 (Millipore cat# 09-872), TET2 (Santa Cruz, cat# sc-136926) and TET3 (Millipore cat# ABE383) were used in this experiment.
Virus and stereotaxic surgery. AAV-TET1 overexpression and AAV-GFP control vectors were the same as reported previously 16 . Tet1 shRNA lentiviral particles (cat# sc-154204-V) and control shRNA lentiviral particles (cat# sc-108080) were purchased from Santa Cruz Biotechnology. The second Tet1 knockdown AAV-Tet1 shRNA construct was designed following published literature 9 . Stereotaxic intraNAc injection was performed according to published protocols 52 . Viral injection sites were verified by confirming the GFP signal in NAc slices under the microscope. Animals with incorrect injection placement were excluded from analyses. Viral manipulation of Tet1 was confirmed using qPCR and western blot. cPP. A standard, unbiased CPP procedure was used as previously described 33 . In brief, 3-4 weeks after viral injection, animals were pretested for 20 min in a photo-beam monitored box with free access to environmentally distinct chambers. The mice were then arranged into control and experimental groups with balanced pretest scores. Mice underwent four 30-min training sessions (saline morning and cocaine in the afternoon) over 2 d. On the test day, mice had 20 min of unrestricted access to all chambers and a CPP score was assigned by subtracting the time spent in the cocaine-paired chamber from the time spent in the salinepaired chamber. Cocaine was injected intraperitoneal at 7.5 mg per kg. 5mc and 5hmc quantification. Genomic DNA was isolated from NAc punches by using Qiagen's DNA purification kit. The liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) quantification of 5mC and 5hmC was performed with established protocols 5, 27 . 5hmc capture and sequencing. 5hmC enrichment and sequencing were performed with a previously described selective chemical labeling method 19, 54 . Genomic DNA was first sonicated into 100-500 bp by using a Covaris instrument. 5hmC labeling reactions were performed in a 100 µl solution containing 50 mM HEPES buffer (pH 7.9), 25 mM MgCl 2 , sonicated DNA, 250 µM UDP-6-N3-Glu, and 2.25 µM wild-type β-glucosyltransferase. DNA substrates were then purified via DNA purification kit (Qiagen). Click chemistry was performed with the addition of 150 µM dibenzocyclooctyne modified biotin into the DNA solution, and incubated at 37 °C for 2 h. Samples were then purified with Pierce Monomeric Avidin Kit (Thermo). After elution, biotin-5-N3-gmC-containing DNA was concentrated and purified using a Qiagen DNA purification kit.
Libraries were generated following the Illumina protocol for "Preparing Samples for ChIP Sequencing of DNA" (cat# 111257047 Rev. A) with 25 ng 5hmC-captured DNA. DNA fragments of ~150-300 bp were size selected through agarose gel-purification after adaptor ligation. PCR-amplified DNA libraries were quantified on Agilent Bioanalyzer and diluted to 6-8 pM for cluster generation and sequencing. 38-cycle single-end sequencing was carried out by use of a Version 4 Cluster Generation (cat# 15002739) and Sequencing Kits and (cat# 15005236) and Version 7.0 recipes. Image processing and sequence extraction were accomplished using the standard Illumina pipeline. Three biological replicates were performed for each condition. mRnA sequencing. 4 µg of total RNA was used for mRNA library construction following instructions of Illumina mRNA sample prep kit (cat# RS-100-0801). npg coverage plots. Coverage plots at TSS, TES, and genebody were generated using ngs.plot 61 . Briefly, we determined the read count for each base-pair and then normalized them by the total library size to get the coverage, or the so-called 'read count per million mapped reads' (RPM). These coverage vectors were then averaged across all the functional regions, such as all TSSs, on the genome to obtain an average profile. For gene bodies, where regions are of variable length, a spline fit was first performed and then sampled at equal intervals so that all coverage vectors were normalized to the same length.
A Supplementary methods checklist is available.
